The Series C financing was led by Elevage Medical Technologies with backing from Patient Square Capital and other investors.
"This significant investment demonstrates continued confidence in our team, our eProtein Discovery system, and our potential to revolutionize the way proteins are made. This funding will accelerate our mission to provide ready-to-use benchtop protein screening and making tools to empower protein scientists around the world. We are excited to enhance our support for our customers, enabling them to make proteins for drug discovery more efficiently and effectively for many years to come."
Vitruvian Partners invests in Options Technology to accelerate global expansion and technology innovation.
"We are delighted to invest in Options, a company with a proven track record of growth and innovation in the capital markets sector. With our financial backing and strategic guidance, we look forward to helping Options further solidify its position as a global leader in financial technology and continue delivering innovative solutions to its customers."